Pharmacological targeting of TNS3 with histone deacetylase inhibitor as a therapeutic strategy in esophageal squamous cell carcinoma

被引：5
|
作者：
Shi, Yang [1 ,2 ]
Xiang, Zheng [4 ]
Yang, Huiyu [1 ,2 ]
Khan, Suliman [5 ]
Li, Ruizhe [3 ]
Zhou, Siran [1 ,2 ]
Ullah, Saif [1 ,2 ]
Zhang, Jiyu [1 ,2 ]
Liu, Bingrong [1 ,2 ]
机构：
[1] Zhengzhou Univ, Dept Gastroenterol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China
[2] Zhengzhou Univ, State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou 450052, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Pathol, Zhengzhou 450052, Peoples R China
[4] Zhengzhou Univ, Henan Univ, Henan Prov Peoples Hosp, Dept Pathol,Peoples Hosp, Zhengzhou 450003, Peoples R China
[5] Zhengzhou Univ, Affiliated Hosp 2, Dept Cerebrovasc Dis, Zhengzhou 450000, Peoples R China
来源：
AGING-US | 2021年 / 13卷 / 11期
基金：
中国国家自然科学基金;
关键词：
histone deacetylase inhibitors; LMK-235; esophageal squamous cell carcinoma; tensin-3; histone acetylation; SRC FAMILY KINASES; HDAC INHIBITORS; PROTEIN; EPIGENETICS; COMBINATION; EXPRESSION; PACKAGE;
D O I：
10.18632/aging.203091
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Histone acetylation which regulates about 2-10% of genes has been demonstrated to be involved in tumorigenesis of esophageal squamous cell carcinoma (ESCC). In this study, we investigated the treatment response of ESCC to selective histone deacetylase inhibitor (HDACi) LMK-235 and potential biomarker predicting the treatment sensitivity. We identified tensin-3 (TNS3) which was highly over-expressed in ESCC as one of the down-regulated genes in response to LMK-235 treatment. TNS3 was found positively correlated with the tumor malignancy and poor prognosis in the patients. Silencing TNS3 significantly inhibited ESCC cell proliferation both in vitro and in vivo, sensitizing the treatment response to LMK-235. Our findings provide an insight into understanding the oncogenic role of TNS3 in ESCC and its clinical application for HDAC targeted therapy of ESCC.
引用
收藏
页码：15336 / 15352
页数：17
相关论文
共 50 条
  • [1] Preclinical assessment of histone deacetylase inhibitor quisinostat as a therapeutic agent against esophageal squamous cell carcinoma
    Zhong, Lei
    Zhou, Shu
    Tong, Rongsheng
    Shi, Jianyou
    Bai, Lan
    Zhu, Yuxuan
    Duan, Xingmei
    Liu, Wenzhao
    Bao, Jinku
    Su, Lingyu
    Peng, Qian
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (04) : 616 - 624
  • [2] Preclinical assessment of histone deacetylase inhibitor quisinostat as a therapeutic agent against esophageal squamous cell carcinoma
    Lei Zhong
    Shu Zhou
    Rongsheng Tong
    Jianyou Shi
    Lan Bai
    Yuxuan Zhu
    Xingmei Duan
    Wenzhao Liu
    Jinku Bao
    Lingyu Su
    Qian Peng
    Investigational New Drugs, 2019, 37 : 616 - 624
  • [3] Comment on "Preclinical assessment of histone deacetylase inhibitor quisinostat as a therapeutic agent against esophageal squamous cell carcinoma"
    Lin, Jiong
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (05) : 1454 - 1455
  • [4] Comment on “Preclinical assessment of histone deacetylase inhibitor quisinostat as a therapeutic agent against esophageal squamous cell carcinoma”
    Jiong Lin
    Investigational New Drugs, 2021, 39 : 1454 - 1455
  • [5] Valproic acid, a histone deacetylase inhibitor, enhances radiosensitivity in esophageal squamous cell carcinoma
    Shoji, Masatoshi
    Ninomiya, Itasu
    Makino, Isamu
    Kinoshita, Jun
    Nakamura, Keishi
    Oyama, Katsunobu
    Nakagawara, Hisatoshi
    Fujita, Hideto
    Tajima, Hidehiro
    Takamura, Hiroyuki
    Kitagawa, Hirohisa
    Fushida, Sachio
    Harada, Shinichi
    Fujimura, Takashi
    Ohta, Tetsuo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (06) : 2140 - 2146
  • [6] Treatment of Cutaneous Squamous Cell Carcinoma With the Topical Histone Deacetylase Inhibitor Remetinostat
    Kilgour, James M.
    Shah, Aatman
    Eichstadt, Shaundra
    Bailey, Irene
    Aasi, Sumaira Z.
    Sarin, Kavita Y.
    JAMA DERMATOLOGY, 2022, 158 (01) : 105 - 107
  • [7] The Potency of a Histone Deacetylase Inhibitor and Reolysin in Head and Neck Squamous Cell Carcinoma
    Old, Matthew
    Jamie-Ramirez, Cristina
    Yu, Jun-Ge
    Kumar, Bhavna
    Kumar, Pawan
    Pan, Quintin
    Lee, John
    Teknos, Theodoros
    Pichiorri, Flavia
    Kaur, Balveen
    MOLECULAR THERAPY, 2016, 24 : S164 - S165
  • [8] Histone deacetylase 8 as a novel therapeutic target in oral squamous cell carcinoma
    Ahn, Mee-Young
    Yoon, Jung-Hoon
    ONCOLOGY REPORTS, 2017, 37 (01) : 540 - 546
  • [9] The histone deacetylase inhibitor panobinostat exerts anticancer effects on esophageal squamous cell carcinoma cells by inducing cell cycle arrest
    Cheng, Yin-Wei
    Liao, Lian-Di
    Yang, Qian
    Chen, Yang
    Nie, Ping-Juan
    Zhang, Xiao-Jun
    Xie, Jian-Jun
    Shan, Bao-En
    Zhao, Lian-Mei
    Xu, Li-Yan
    Li, En-Min
    CELL BIOCHEMISTRY AND FUNCTION, 2018, 36 (08) : 398 - 407
  • [10] Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma
    Toh, Y
    Yamamoto, M
    Endo, K
    Ikeda, Y
    Baba, H
    Kohnoe, S
    Yonemasu, H
    Hachitanda, Y
    Okamura, T
    Sugimachi, K
    ONCOLOGY REPORTS, 2003, 10 (02) : 333 - 338
12345